Effect of Shatpushpa- Shatavari churna and Shatpushpa taila UB in Artavakshaya.

A comparative clinical evaluation of shatpushpa shatavari churna and shatpushpa taila uttar vasti in the management of artava kshaya with special reference to oligohypomenorrhoea - NIL

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057499

Enrollment

Registered

2023-09-12

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N915- Oligomenorrhea, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Married patients fulfilling the cardinal symptoms of Artavakshaya. 2.Patients between the age group of 20-40 years. 3.Patients willing to participate in the study with proper written consent.

Exclusion criteria

Exclusion criteria: 1.Patient having systemic diseases which interfere with the present study. 2.Pregnant & Lactating women. 3.Patient on OCPs, IUCD. 4.Patient with congenital anomalies of uterus or ovaries. 5.Any other pelvic pathology or malignancy. 6.Anaemic patients (Hb less than 8 gm/dL)

Design outcomes

Primary

Measure	Time frame
To assess the efficacy of trial therapy on subjective parameters likeInterval between two cycles, Duration of Menstrual Bleeding,Amount of Menstrual blood loss & Pain during Menstruation. Timepoint: 2 month	—

Secondary

Measure	Time frame
To assess the effect of trial therapy in the management of Artavakshaya. Timepoint: 8 weeks	—

Countries

India

Contacts

Public ContactProf Shashi Sharma

State ayurvedic college and hospital Lucknow Uttar Pradesh

bedar.shashi@gmail.com8795545443

Outcome results